毕得医药
(688073)
| 流通市值：20.00亿 | | | 总市值：42.03亿 |
| 流通股本：4323.42万 | | | 总股本：9088.29万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 889,356,898.34 | 957,626,154.2 | 1,281,970,189.43 | 1,274,075,533.8 |
| 应收票据及应收账款 | 234,764,760.95 | 231,936,108.98 | 245,290,221.91 | 237,354,200.17 |
| 其中：应收票据 | 5,454,926.74 | 678,937.9 | 1,939,932.39 | 2,344,167.13 |
| 应收账款 | 229,309,834.21 | 231,257,171.08 | 243,350,289.52 | 235,010,033.04 |
| 预付款项 | 10,011,832.71 | 10,188,862.08 | 9,403,896.61 | 9,218,853.21 |
| 其他应收款合计 | 12,583,694.24 | 10,137,632.37 | 10,024,061.55 | 10,657,367.16 |
| 存货 | 709,915,587.42 | 686,131,773.28 | 670,410,703.61 | 699,430,441.56 |
| 其他流动资产 | 21,572,996.71 | 16,100,310.08 | 22,649,170.98 | 30,307,215.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,160,696,619.69 | 2,177,018,736.88 | 2,239,748,244.09 | 2,261,166,147.47 |
| 非流动资产: | | | | |
| 固定资产 | 35,389,227.52 | 37,619,691.25 | 41,419,012 | 42,780,780.63 |
| 在建工程 | 67,581,944.32 | - | - | - |
| 使用权资产 | 44,275,139.72 | 50,528,530.04 | 48,090,758.4 | 54,540,850.96 |
| 无形资产 | 4,089,293.15 | 4,215,432.05 | 530,623.81 | 600,719.35 |
| 长期待摊费用 | 26,465,301.41 | 29,515,978.22 | 33,063,279.5 | 37,579,040.94 |
| 递延所得税资产 | 13,667,887.09 | 15,248,654.73 | 18,841,531.42 | 18,360,441.47 |
| 其他非流动资产 | - | - | 226,059.28 | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 191,468,793.21 | 137,128,286.29 | 142,171,264.41 | 153,861,833.35 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,352,165,412.9 | 2,314,147,023.17 | 2,381,919,508.5 | 2,415,027,980.82 |
| 流动负债: | | | | |
| 短期借款 | 58,390,582 | 37,645,305.32 | 39,751,310.37 | 231,234.01 |
| 交易性金融负债 | - | - | 948,481.61 | 2,436,422.44 |
| 应付票据及应付账款 | 179,513,995.38 | 181,243,788.02 | 171,470,408.33 | 179,566,402.86 |
| 应付账款 | 179,513,995.38 | 181,243,788.02 | 171,470,408.33 | 179,566,402.86 |
| 合同负债 | 24,897,935.43 | 23,646,764.87 | 19,820,952.81 | 29,072,493.83 |
| 应付职工薪酬 | 17,748,391.87 | 16,288,053.42 | 21,120,531.62 | 21,560,093.25 |
| 应交税费 | 18,361,588.8 | 18,015,301.05 | 23,097,694.45 | 21,469,686.94 |
| 其他应付款合计 | 480,167.77 | 540,304.51 | 784,475.84 | 1,638,037.19 |
| 一年内到期的非流动负债 | 13,966,526.3 | 16,104,506.75 | 17,047,292.97 | 15,879,402.55 |
| 其他流动负债 | 2,648,003.56 | 2,530,487.57 | 2,477,147.05 | 3,116,329.81 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 316,007,191.11 | 296,014,511.51 | 296,518,295.05 | 274,970,102.88 |
| 非流动负债: | | | | |
| 租赁负债 | 31,011,406.1 | 35,096,786.17 | 32,041,407.43 | 41,185,511.52 |
| 预计负债 | - | - | - | 1,267,641.51 |
| 递延所得税负债 | 7,173,887.25 | 7,873,258.44 | 8,119,496.18 | 8,062,572.58 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 38,185,293.35 | 42,970,044.61 | 40,160,903.61 | 50,515,725.61 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 354,192,484.46 | 338,984,556.12 | 336,679,198.66 | 325,485,828.49 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 90,882,948 | 90,882,948 | 90,882,948 | 90,882,948 |
| 资本公积 | 1,754,611,520.07 | 1,754,240,743.08 | 1,753,930,769.57 | 1,753,537,094.5 |
| 减:库存股 | 99,991,734.5 | 87,420,246.76 | 70,431,395.78 | - |
| 其他综合收益 | -3,589,321.33 | -6,585,665.22 | -7,301,092.85 | -6,962,028.07 |
| 盈余公积 | 27,497,479.99 | 27,497,479.99 | 27,497,479.99 | 27,497,479.99 |
| 未分配利润 | 228,562,036.21 | 196,547,207.96 | 250,661,600.91 | 224,586,657.91 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,997,972,928.44 | 1,975,162,467.05 | 2,045,240,309.84 | 2,089,542,152.33 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,997,972,928.44 | 1,975,162,467.05 | 2,045,240,309.84 | 2,089,542,152.33 |
| 负债和股东权益合计 | 2,352,165,412.9 | 2,314,147,023.17 | 2,381,919,508.5 | 2,415,027,980.82 |
| 公告日期 | 2024-10-24 | 2024-08-29 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |